Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CABA Cabaletta Bio

交易中 04-30 15:35:58 EDT

10.71

+0.23

+2.15%

最高10.72	最低10.16	成交量116.17万
今开10.46	昨收10.48	日振幅5.34%
总市值5.17亿	流通市值4.22亿	总股本4,825万
成交额1,216万	换手率2.95%	流通股本3,941万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CABA","market":"US","secType":"STK","nameCN":"Cabaletta Bio","latestPrice":10.705,"timestamp":1714505754841,"preClose":10.48,"halted":0,"volume":1161690,"delay":0,"floatShares":39406596,"shares":48249115,"eps":-1.652788,"marketStatus":"交易中","marketStatusCode":2,"change":0.225,"latestTime":"04-30 15:35:58 EDT","open":10.46,"high":10.72,"low":10.1601,"amount":12159054.914549999,"amplitude":0.053426,"askPrice":10.71,"askSize":201,"bidPrice":10.7,"bidSize":626,"shortable":0,"etf":0,"ttmEps":-1.652788,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714507200000},"adr":0,"listingDate":1571976000000,"adjPreClose":10.48,"preHourTrading":{"tag":"盘前","latestPrice":10.54,"preClose":10.48,"latestTime":"08:28 EDT","volume":99,"amount":1047.759966,"timestamp":1714480125670},"postHourTrading":{"tag":"盘后","latestPrice":10.67,"preClose":10.48,"latestTime":"19:36 EDT","volume":6755,"amount":70829.64,"timestamp":1714433762711},"volumeRatio":0.527688},"requestUrl":"/m/hq/s/CABA/wiki","defaultTab":"wiki","newsList":[{"id":"2431470861","title":"Cabaletta Bio, Inc.盘中异动 早盘快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431470861","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431470861?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:57","pubTimestamp":1714399078,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时57分，Cabaletta Bio, Inc.股票出现波动，股价急速跳水5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921575887e84c0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921575887e84c0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430788251","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.01%报11.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430788251","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430788251?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:20","pubTimestamp":1714148434,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日00时20分，Cabaletta Bio, Inc.股票出现波动，股价急速跳水5.01%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270020357a564b17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270020357a564b17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430285417","title":"Cabaletta Bio, Inc.盘中异动 早盘大幅下跌5.40%报12.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430285417","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430285417?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:35","pubTimestamp":1714052154,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时35分，Cabaletta Bio, Inc.股票出现波动，股价大幅下跌5.40%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521355487e83b13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521355487e83b13&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429116005","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.03%报13.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429116005","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429116005?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:50","pubTimestamp":1713883804,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时50分，Cabaletta Bio, Inc.股票出现波动，股价急速拉升5.03%。截至发稿，该股报13.99美元/股，成交量9.4384万股，换手率0.20%，振幅3.90%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232250047a54f1d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232250047a54f1d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428651660","title":"Cabaletta Bio, Inc.盘中异动 下午盘股价大跌5.01%报13.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428651660","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428651660?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:23","pubTimestamp":1713551018,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时23分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.01%。截至发稿，该股报13.27美元/股，成交量49.1414万股，换手率1.02%，振幅7.16%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200223397921ec57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200223397921ec57&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428236393","title":"Cabaletta Bio, Inc.盘中异动 临近午盘快速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428236393","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428236393?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:51","pubTimestamp":1713369109,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日23时51分，Cabaletta Bio, Inc.股票出现波动，股价大幅下挫5.16%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417235150861e6c0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417235150861e6c0c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427754601","title":"Cabaletta Bio, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427754601","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427754601?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:14","pubTimestamp":1712949289,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时14分，Cabaletta Bio, Inc.股票出现波动，股价快速跳水5.08%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.63%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413031450792040c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413031450792040c4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426173492","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.05%报17.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426173492","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426173492?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:45","pubTimestamp":1712756731,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时45分，Cabaletta Bio, Inc.股票出现异动，股价急速下挫5.05%。截至发稿，该股报17.87美元/股，成交量12.5606万股，换手率0.26%，振幅3.24%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102145317a51e885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102145317a51e885&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426142028","title":"Cabaletta Bio, Inc.盘中异动 下午盘股价大涨5.04%报18.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426142028","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426142028?lang=zh_cn&edition=full","pubTime":"2024-04-10 02:54","pubTimestamp":1712688876,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日02时54分，Cabaletta Bio, Inc.股票出现异动，股价急速上涨5.04%。截至发稿，该股报18.95美元/股，成交量52.5057万股，换手率1.09%，振幅6.87%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410025436861e4495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410025436861e4495&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425566295","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.00%报16.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425566295","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425566295?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:05","pubTimestamp":1712325917,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时05分，Cabaletta Bio, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报16.92美元/股，成交量6.3995万股，换手率0.13%，振幅6.70%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405220518861e38cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405220518861e38cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424397934","title":"Cabaletta Bio, Inc.盘中异动 大幅拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424397934","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424397934?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:34","pubTimestamp":1712237681,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时34分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.17%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042134427a51066e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042134427a51066e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421503298","title":"Cabaletta Bio, Inc.2023财年实现净利润-67.68百万美元，同比减少27.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421503298","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421503298?lang=zh_cn&edition=full","pubTime":"2024-03-22 15:19","pubTimestamp":1711091975,"startTime":"0","endTime":"0","summary":"12月31日，Cabaletta Bio, Inc.公布财报，公告显示公司2023财年净利润为-67.68百万美元，同比减少27.75%；其中营业收入为0.00美元，每股基本收益为-1.65美元。从资产负债表来看，Cabaletta Bio, Inc.总负债17.45百万美元，其中短期债务3.56百万美元，资产负债比为0.15，流动比率为0.16。机构评级：截至2023年12月31日，当前有7家机构对Cabaletta Bio, Inc.目标价做出预测，其中目标均价为34.71美元，其中最低目标价为25.00美元，最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032215443987a5de74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032215443987a5de74&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421046695","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.08%报17.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421046695","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421046695?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:39","pubTimestamp":1711028349,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时39分，Cabaletta Bio, Inc.股票出现异动，股价快速跳水5.08%。截至发稿，该股报17.20美元/股，成交量7.0277万股，换手率0.16%，振幅5.30%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213910861e0190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213910861e0190&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420470851","title":"Cabaletta Bio, Inc.盘中异动 早盘大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420470851","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420470851?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:53","pubTimestamp":1710769992,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时53分，Cabaletta Bio, Inc.股票出现波动，股价急速跳水5.07%。截至发稿，该股报17.79美元/股，成交量4.8589万股，换手率0.11%，振幅5.07%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318215312861df1d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318215312861df1d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419071306","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.09%报19.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419071306","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419071306?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:55","pubTimestamp":1710424518,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时55分，Cabaletta Bio, Inc.股票出现波动，股价快速跳水5.09%。截至发稿，该股报19.21美元/股，成交量6.6327万股，换手率0.15%，振幅4.17%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421551887e78f34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421551887e78f34&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418539832","title":"Cabaletta Bio Inc   预计每股亏损39美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2418539832","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418539832?lang=zh_cn&edition=full","pubTime":"2024-03-12 20:40","pubTimestamp":1710247214,"startTime":"0","endTime":"0","summary":"   * Cabaletta Bio Inc    预计在3月14日公布截至2023年12月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对卡巴莱塔生物公司的平均预期是每股亏损39美分。* 华尔街对卡巴莱塔生物公司 12 个月目标价的中位数为 31.00 美元，高于上一交易日的收盘价 20.38 美元。3月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416014702","title":"Cabaletta Bio, Inc.盘中异动 大幅跳水5.26%报22.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416014702","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416014702?lang=zh_cn&edition=full","pubTime":"2024-03-04 22:53","pubTimestamp":1709564035,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日22时53分，Cabaletta Bio, Inc.股票出现波动，股价大幅跳水5.26%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042253567a495217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042253567a495217&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416641713","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416641713","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416641713?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:50","pubTimestamp":1709304603,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时50分，Cabaletta Bio, Inc.股票出现异动，股价快速拉升5.46%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122500379165eed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122500379165eed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415583048","title":"Cabaletta Bio Inc盘中异动 快速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415583048","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415583048?lang=zh_cn&edition=full","pubTime":"2024-02-29 04:52","pubTimestamp":1709153535,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日04时52分，Cabaletta Bio Inc股票出现异动，股价急速跳水5.10%。Cabaletta Bio Inc股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Vivani Medical Inc、Vtv Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Revelation Biosciences Inc较为活跃，换手率分别为6655.50%、286.71%、195.92%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc，振幅分别为424.75%、219.84%、129.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022904521587e746dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022904521587e746dd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414831246","title":"Cabaletta Bio Inc盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414831246","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414831246?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:50","pubTimestamp":1708962638,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时50分，Cabaletta Bio Inc股票出现波动，股价快速上涨5.23%。截至发稿，该股报23.56美元/股，成交量12.2264万股，换手率0.29%，振幅4.48%。Cabaletta Bio Inc股票所在的生物技术行业中，整体跌幅为0.15%。Cabaletta Bio Inc公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623503887e732ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623503887e732ed&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cabalettabio.com","stockEarnings":[{"period":"1week","weight":-0.2132},{"period":"1month","weight":-0.3857},{"period":"3month","weight":-0.5047},{"period":"6month","weight":-0.2895},{"period":"1year","weight":0.0096},{"period":"ytd","weight":-0.5383}],"compareEarnings":[{"period":"1week","weight":0.0207},{"period":"1month","weight":-0.0249},{"period":"3month","weight":0.0391},{"period":"6month","weight":0.2068},{"period":"1year","weight":0.2263},{"period":"ytd","weight":0.0731}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发工程化T细胞疗法，这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的，也许是治疗性的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.047408},{"month":2,"riseRate":0.2,"avgChangeRate":-0.139771},{"month":3,"riseRate":0.2,"avgChangeRate":-0.173851},{"month":4,"riseRate":0.4,"avgChangeRate":-0.09098},{"month":5,"riseRate":0.5,"avgChangeRate":0.024444},{"month":6,"riseRate":0.5,"avgChangeRate":0.042228},{"month":7,"riseRate":0.75,"avgChangeRate":0.015419},{"month":8,"riseRate":0.5,"avgChangeRate":0.034127},{"month":9,"riseRate":0.75,"avgChangeRate":-0.005587},{"month":10,"riseRate":0.75,"avgChangeRate":0.432011},{"month":11,"riseRate":0.8,"avgChangeRate":0.442874},{"month":12,"riseRate":0.6,"avgChangeRate":0.132954}],"exchange":"NASDAQ","name":"Cabaletta Bio","nameEN":"Cabaletta Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cabaletta Bio,CABA,Cabaletta Bio股票,Cabaletta Bio股票老虎,Cabaletta Bio股票老虎国际,Cabaletta Bio行情,Cabaletta Bio股票行情,Cabaletta Bio股价,Cabaletta Bio股市,Cabaletta Bio股票价格,Cabaletta Bio股票交易,Cabaletta Bio股票购买,Cabaletta Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}